Exosome Derived Micro RNA: A Promising Modality in the Treatment of Spinal Cord Injury and Peripheral Neuropathy
Advanced Pharmaceutical Bulletin · 15.06.2026 · 16 (2) · 216-217
DOI: 10.34172/apb.46604 ↗Kurz gefasst
Leserbrief in der Zeitschrift Advanced Pharmaceutical Bulletin, online erschienen am 10.05.2026. Verfasst von Aminath Efa Ibrahim und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, The Maldives National University, Male', Maldives. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- School of Medicine, The Maldives National University, Male', Maldives.
- All India Institute of Medical Sciences, Kalyani, India.
ORCID-Profile: Aminath Efa Ibrahim, Kannan Subbaram, Razana Faiz, Sheeza Ali, Queen Alice Arul
Zitieren
APA
Ibrahim, A. E., Subbaram, K., Faiz, R., Ali, S., & Arul, Q. A. (2026). Exosome Derived Micro RNA: A Promising Modality in the Treatment of Spinal Cord Injury and Peripheral Neuropathy. Advanced Pharmaceutical Bulletin, 16(2), 216-217. https://doi.org/10.34172/apb.46604
Vancouver
Ibrahim AE, Subbaram K, Faiz R, Ali S, Arul QA. Exosome Derived Micro RNA: A Promising Modality in the Treatment of Spinal Cord Injury and Peripheral Neuropathy. Advanced Pharmaceutical Bulletin. 2026;16(2):216-217. doi:10.34172/apb.46604
BibTeX
@article{Ibrahim2026,
author = {Ibrahim, Aminath Efa and Subbaram, Kannan and Faiz, Razana and Ali, Sheeza and Arul, Queen Alice},
title = {Exosome Derived Micro RNA: A Promising Modality in the Treatment of Spinal Cord Injury and Peripheral Neuropathy},
journal = {Advanced Pharmaceutical Bulletin},
year = {2026},
volume = {16},
number = {2},
pages = {216--217},
doi = {10.34172/apb.46604}
}
EUVIMED